| |
| |
|
| Insider
Information: |
Patel Sanj K |
| Relationship: |
|
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
63,012 |
|
|
Indirect Shares
|
109,795 |
|
|
| Direct
Value |
$1,272,212 |
|
|
|
Indirect Value
|
$2,216,761 |
|
|
| Total
Shares |
172,807 |
|
|
| Total
Value |
$3,488,973 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Synageva BioPharma Corp |
GEVA |
President & CEO, Direc... |
2015-06-22 |
0 |
2015-06-22 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-04-08 |
63,012 |
2024-04-08 |
109,795 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GEVA |
Synageva BioPharma Corp |
Director and President/CEOOffi |
• • – |
2011-11-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,031 |
|
- |
|
| GEVA |
Synageva BioPharma Corp |
Director and President/CEOOffi |
• • – |
2011-11-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
286 |
|
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2015-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
72,000 |
73,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2015-06-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(73,031) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2015-06-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(286) |
0 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2018-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
135,889 |
245,685 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
Chairman & CEO |
• • – |
2022-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,569 |
6,569 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2022-03-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,555 |
23,202 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2022-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,569 |
24,325 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2023-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,569 |
28,965 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2023-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,002 |
39,038 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2023-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,992 |
45,507 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,992 |
52,566 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2023-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,569 |
54,703 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,482 |
58,998 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHAIRMAN & CEO |
• • – |
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,992 |
67,087 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-03-23 |
4 |
OE |
$0.95 |
$47,500 |
D/D |
50,000 |
51,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-08-31 |
4 |
OE |
$0.95 |
$14,428 |
D/D |
15,187 |
16,218 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-09-04 |
4 |
OE |
$0.95 |
$52,072 |
D/D |
54,813 |
55,844 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-11-30 |
4 |
OE |
$0.95 |
$4,750 |
D/D |
5,000 |
6,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-03 |
4 |
OE |
$0.95 |
$28,500 |
D/D |
30,000 |
31,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-04 |
4 |
OE |
$0.95 |
$21,850 |
D/D |
23,000 |
24,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-05 |
4 |
OE |
$0.95 |
$11,400 |
D/D |
12,000 |
13,031 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-13 |
4 |
OE |
$0.95 |
$13,680 |
D/D |
14,400 |
15,431 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
President & CEO |
• • – |
2012-12-14 |
4 |
OE |
$0.95 |
$12,617 |
D/D |
13,281 |
14,312 |
0 |
- |
|
93 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
